Recent Company News

• 04:11 AM ET Oct 17, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 05:20 PM ET Oct 15, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 03:32 PM ET Oct 16, 2025
  

  Cellectis' R&D Day highlights lasme-cel's potential to address significant unmet need for patients with r/r b-all (€4.07, 0.00)

• 10:06 AM ET Oct 16, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (200 total)

• 09:18 AM ET Oct 16, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:51 AM ET Oct 15, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:26 AM ET Oct 16, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:03 AM ET Oct 16, 2025
  

  Cellectis hosting R&D day today showcasing pipeline progress and long-term value drivers (€4.41, +0.79)